ABOUT ORGANOX: OrganOx is a commercial stage organ technology company dedicated to developing technologies to improve outcomes for patients with acute or chronic organ failure. The company was established as a spin out of the University
Founded by Paul Anthony, creator and co-founder of Primer (Series B, $425M valuation), Colossal is building at the intersection of generative app development and commerce infrastructure. Think: Lovable for commerce, but for non-developers. Were backed by Tier